Webinar live date: Tuesday 10 December 2019 07:00 [PST] 10:00 [EST] 15:00 [GMT]. LC–MS based large molecule bioanalysis platform was developed, validated and applied for drug screening and preclinical pharmacokinetics.
Webinar live date: Thursday 5 December 2019, 07:00 [PST] 10:00 [EST] 15:00 [GMT]. The aim of DMPK is to enable scientists to learn the safety and efficacy of new molecular entities. HRMS is an important analytical tool used to study DMPK that continues to gain traction when quantifying molecules.
Webinar live date: Tuesday 3 December 2019 07:00 [PST] 10:00 [EST] 15:00 [GMT]. Absolute quantitation of intact biotherapeutics is enabled through advances in immunocapture techniques coupled to LC–MS.
Webinar live date: Thursday 12 December 2019 07:00 [PST] 10:00 [EST] 15:00 [GMT]. On December 12, join us as we discuss, with supporting case studies, how hybridization ELISA can be an effective approach to quantify antisense oligonucleotides in circulation and in their targeted tissue.
Panel discussion available on demand. In this free panel discussion, our experts will provide insights into their own research using oligonucleotides, including the most common challenges encountered, key trends they have seen as the field develops and their opinions on the future outlook of the technology.
Webinar now available on demand. Learn about the sensitivity gains afforded by microflow chromatography vs high-flow and what potential this has for Met ID. See how this translates to stronger spectra in turn resulting in more metabolites being identified and characterized.
Thank you everyone who attended our live webinar ‘Exploratory biomarker testing: to qualify or validate the assay? The latest scientific and regulatory considerations for biomarker validation‘ in association with BioAgilytix.
Webinar available on demand. A ‘tips and tricks’ approach to understanding and optimizing chromatography of oligonucleotides. Taking into consideration the nature of the oligonucleotide you are interested in, you will be able to make informed choices about what approach to use.
Webinar available on demand. An overview of Gyrolab immunoassays and their utility in CMC target binding assays for batch release and stability assessment. Also, for preclinical and clinical PK analysis with a view to transferring assays to a CRO.
Webinar available on demand. In this free panel discussion, our experts will provide insights into their own research using ligand binding assays including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
Mass Spectrometry (LC–MS/MS and LC–HRMS) approaches for bioanalysis of antibody–drug conjugates and applications will be presented.
TriAltus Bioscience (AL, USA) has announced the launch of a new affinity chromatography resin for the cl7/im7 protein purification system, with double the binding capacity of the original resin for the single-step protein purification system.
A research team from Singapore University of Technology and Design (Singapore) has developed a microfluidic impedance flow cytometry device that could be capable of simultaneously measuring the lateral position and biophysical properties of single cells.
Researchers based at the University of Toronto (ON, CA) have developed a microfluidic device that could be used to separate malignant plasma cells from healthy red blood cells. The device could have the potential to detect and monitor blood cancer.
In this interview from 3DMedNet, Laura Mercolini (Alma Mater Studiorum, University of Bologna, Italy) discusses how the latest 3D printing techniques and technology are enhancing bioanalytical research: from sampling to sample handling, pretreatment and instrumental analysis.